August 12, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Updates on APEX-related Personal Jurisdiction Considerations Since SnapRays
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Updates on APEX-related Personal Jurisdiction Considerations Since SnapRays
Biotechnology

Updates on APEX-related Personal Jurisdiction Considerations Since SnapRays

By Newsroom
Last updated: February 8, 2026
1 Min Read
Share


Last year we discussed the implications of the Supreme Court’s choice not to review the Federal Circuit’s SnapRays decision for patent owners that rely on the Amazon Patent Evaluation Express (“APEX”) program. A recent case out of the Northern District of California illustrates the limits of the SnapRays decision.

As we highlighted, the APEX program offers a streamlined (and less expensive) way for utility patent owners to remove infringing product listings on Amazon.com. Using the program, however, opens the door for the accused seller to file a declaratory judgment action in district court. Which district court a seller can file in was…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

New York’s Climate Change Superfund Act

Environmental Science
April 5, 2025

Compound Registration at Scale: Speed & Performance

Every new compound that enters a pharmaceutical or biotech organization’s database must clear one critical…

August 10, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Federal Circuit Eases Expert Admissibility Threshold

In a decision that is quickly gaining attention, the Federal Circuit held that the district court abused its discretion by…

Biotechnology
February 1, 2026

Federal Circuit Reverses $4.7M Verdict in Labcorp v. QIAGEN: Claim Scope and Doctrine of Equivalents in the Crosshairs

The Federal Circuit recently reversed a $4.7M verdict in a patent lawsuit involving two patents concerning next-generation sequencing methods—U.S. Patent…

Biotechnology
December 21, 2025

Congress Joins the Biomanufacturing Onshoring Party

In mid-November 2025, Congress introduced the Biomanufacturing Excellence Act of 2025 (H.R. 6089) to establish a dedicated national center aimed…

Biotechnology
November 23, 2025

Sigray, Inc. v. Carl Zeis X-Ray Microscopy, Inc.—When does “No” Projection Magnification Mean “No”? |

In Sigray, Inc, v. Carl Zeis X-Ray , appeal 2023-2211 (Fed. Cir., May 23, 2025), the panel reviewed the Board’s…

Biotechnology
June 20, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Compound Registration at Scale: Speed & Performance
August 10, 2026
TAOC Presentations at the Upcoming Fall 2026 ACS Meeting
August 9, 2026
Latigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs
August 9, 2026
New Stroke Treatment Turns Brain Cavities Into Repair Hubs
August 9, 2026

Life Science Magazines

A New Blueprint: Innovations in DNA Synthesis
July 7, 2026
Inside HCP Decision-Making – The 2026 Access Landscape
July 6, 2026
Checklist for Submitting to an Institutional Review Board
July 2, 2026
Unlocking the Power of Primary Care in Cronic Disease Research
July 2, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?